Tilt Investment Management Holdings PBC Cuts Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Tilt Investment Management Holdings PBC lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 24.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,414 shares of the medical equipment provider’s stock after selling 453 shares during the period. Tilt Investment Management Holdings PBC’s holdings in Intuitive Surgical were worth $477,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Liberty Capital Management Inc. grew its holdings in Intuitive Surgical by 3.8% in the 4th quarter. Liberty Capital Management Inc. now owns 815 shares of the medical equipment provider’s stock worth $275,000 after acquiring an additional 30 shares during the last quarter. Miracle Mile Advisors LLC grew its stake in shares of Intuitive Surgical by 2.3% in the fourth quarter. Miracle Mile Advisors LLC now owns 1,438 shares of the medical equipment provider’s stock worth $485,000 after purchasing an additional 32 shares during the last quarter. Ausdal Financial Partners Inc. increased its holdings in Intuitive Surgical by 1.5% during the 4th quarter. Ausdal Financial Partners Inc. now owns 2,192 shares of the medical equipment provider’s stock valued at $739,000 after purchasing an additional 33 shares during the period. Venturi Wealth Management LLC raised its position in Intuitive Surgical by 10.7% during the 4th quarter. Venturi Wealth Management LLC now owns 341 shares of the medical equipment provider’s stock valued at $115,000 after purchasing an additional 33 shares during the last quarter. Finally, Modera Wealth Management LLC lifted its holdings in Intuitive Surgical by 2.0% in the 3rd quarter. Modera Wealth Management LLC now owns 1,715 shares of the medical equipment provider’s stock worth $501,000 after buying an additional 34 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.2 %

NASDAQ:ISRG traded down $0.58 on Thursday, reaching $373.59. 1,379,025 shares of the stock traded hands, compared to its average volume of 1,631,836. The company has a market capitalization of $132.42 billion, a price-to-earnings ratio of 74.39, a PEG ratio of 5.88 and a beta of 1.36. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $403.76. The company’s fifty day simple moving average is $387.56 and its 200 day simple moving average is $342.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, January 23rd. The medical equipment provider reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.48 by $0.12. Intuitive Surgical had a net margin of 25.24% and a return on equity of 13.11%. The company had revenue of $1.93 billion during the quarter, compared to the consensus estimate of $1.89 billion. During the same quarter last year, the firm earned $0.91 earnings per share. The firm’s quarterly revenue was up 16.6% compared to the same quarter last year. Equities analysts anticipate that Intuitive Surgical, Inc. will post 4.93 EPS for the current fiscal year.

Insider Activity

In related news, Director Alan J. Levy sold 2,000 shares of Intuitive Surgical stock in a transaction dated Friday, January 26th. The stock was sold at an average price of $370.20, for a total value of $740,400.00. Following the completion of the sale, the director now directly owns 25,319 shares in the company, valued at approximately $9,373,093.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, Director Alan J. Levy sold 2,000 shares of the firm’s stock in a transaction dated Friday, January 26th. The shares were sold at an average price of $370.20, for a total transaction of $740,400.00. Following the sale, the director now owns 25,319 shares of the company’s stock, valued at approximately $9,373,093.80. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 20,296 shares of Intuitive Surgical stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $393.80, for a total transaction of $7,992,564.80. Following the completion of the sale, the executive vice president now owns 5,507 shares of the company’s stock, valued at $2,168,656.60. The disclosure for this sale can be found here. Insiders have sold a total of 248,418 shares of company stock valued at $95,927,097 over the last ninety days. 0.90% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

ISRG has been the topic of several research analyst reports. Piper Sandler boosted their target price on Intuitive Surgical from $325.00 to $425.00 and gave the company an “overweight” rating in a research note on Wednesday, January 24th. StockNews.com lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Citigroup lifted their target price on shares of Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Truist Financial boosted their price target on shares of Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a research report on Wednesday, January 24th. Finally, Barclays raised their price objective on shares of Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a report on Thursday, January 25th. Five research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $375.70.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.